HR2389/S1302 - Resident Physician Shortage Reduction Act
S2333 - Public Health Workforce Loan Repayment Act
Health Workforce Resilience Act
S665/HR 4942 Conrad 30 and Physician Access Reauthorization Act
CLIA Waiver
PREVENT Pandemics Act
CURES 2.0
To prevent across-the-board direct spending cuts
Cytotechnologist labor rates
Remote digital telepathology
S 1000/HR 2377 SALSA
S 2140 - Patient Eligibility Restoration Act
HR 977 - legislation that would repeal provisions prohibiting self-referrals to new or expanded POHs.
HR 1202/S 704 - REDI Act
HR 2761 - SPARC act
HR 2764/S1229 - Green New Deal for Health
HR 3248 - Diagnostic Lab Testing Transparency Act
H.R. 3561, the Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act of 2023
Student loan repayment for FPs
HR 4527 - HEALTH DATA Act
Primary Care and Health Workforce Expansion Act
S 1994 Counting Veterans Cancer Act
HR 4875 Doctors in our Borders Act
HR 2474 - Strengthening Medicare for Patients and Providers Act
Continuing Appropriations Act, 2024 and Other Extensions Act
Further Continuing Appropriations and Other Extensions Act, 2024
HR 6683
Gene Therapy
Precision Medicine Answers for Kids Today Act
S.3018/H.R.3173 the Improving Seniors Timely Access to Care Act of 2021
Dr. Lorna Breen Health Care Provider Protection Act
PREVAIL
HR 6371 - budget neutrality bill
EDUCATE Act - Murphy DEI Bill
Issues relating to surprise medical bills
Pandemic and All-Hazards Preparedness Act (PAHPA) Reauthorization
Verifying Accurate Leading-Edge IVCT Development (VALID) Act
Advocating for relief from cuts to evaluation and management codes within Medicare
Issues relating to the debt limit
Issues relating to site-neutral payments
Issue relating to artificial intelligence
Issues relating to combatting fentanyl crisis
Issues relating to Medicare coverage pathways
Researching Long Covid
Fees paid on electronically submitting to insurers
Issues relating to the Clinical Laboratory Fee Schedule
Issues relating to forensic pathologist Loan repayment
funding for the CDC AMD program
Funding for lab test harmonization
Issues surrounding Health Data Privacy
Issues surrounding the Change Healthcare Cyber Attack
Duration: January 1, 2008
to
present
General Issues: Health Issues , Medicare/Medicaid , Law Enforcement/Crime/Criminal Justice , Defense , Medical/Disease Research/Clinical Labs , Torts
Spending: about $17,540,482 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2008: U.S. Senate, House of Representatives, House of Representatives, Senate, Defense - Dept of (DOD), Health & Human Services - Dept of (HHS), Office of Management & Budget (OMB)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist
Covered positions?
Michael Giuliani
Senior Director, Legislation and Political Action
Senior Director, Legislation & Political Action
John Scott
Vice President, Advocacy
Vice President, Policy and Advocacy
Vice President, Division of Advocacy
Vice President, Division of Advocacy
Mikael Troubh
Assistant Director, Legislation and Political Actio
Assistant Director, Legislation & Political Action
Asst. Director, Legislation & Political Action
Assistant Director,Legislation and Political Action
Assistant Director, Legislation and Political Action
DARREN FENWICK
Assistant Director, Legislation and Political Actio
Assistant Director, Legislation & Political Action
Asst. Director, Legislation & Political Action
Assistant Director,Legislation and Political Action
Assistant Director, Legislation and Political Action
Denise Bell
Director, Legislation and Political Action
Director, Legislation & Political Action
Director, Legislative Affairs and Political Action
Director, Federal Legislative Affairs
Director, Federal and Legislative Affairs
Director, Federal and State Affairs
Director, Federal Legsialtive Affairs
Director, Federal Affairs
Christopher Donnellan
Asst. Director, Legislative Affairs & Political Acti
Asst. Director, Legislative Affairs and Political Acti
Asst. Diretor, Legislative Affairs and Political Acti
Asst. Director, Legislation and Political Action
Assistant Director, Federal Legislative Affairs
Assistant Director, Federal and Legislative Affairs
Assistant Director, Federal and State Affairs
Christoper Donnellan
Asst. Director, Legislation and Political Action
Assistant Director, Federal Legislative Affairs
Christopher Sherin
Assistant Director, Federal Legislative Affairs
Assistant Director, Federal and Legislative Affairs
Assistant Director, Federal Legsialtive Affairs
Legislative Assistant, Federal Legislative Affairs
Rebecca Spangler
Assistant Director, Federal Legislative Affairs
Assistant Director, Federal Affairs
Chris Donnellan
Assistant Director, Federal Legislative Affairs
Assistant Director, Federal Affairs
Chris Sherin
Assistant Director, Federal Affairs
Denise J. Bell
Director, Federal Legislative Affairs
Sarah Bogdan
n/a
Michael Brzica
n/a
Michael Hurlbut
n/a
Hannah Burriss
n/a
Kristin McDonald
n/a
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
1st Quarter, 2024
In Q1, College of American Pathologists had in-house lobbyists. The report was filed on April 19.
Original Filing: 301564566.xml
Lobbying Issues
HR2389/S1302 - Resident Physician Shortage Reduction Act
S2333 - Public Health Workforce Loan Repayment Act
Health Workforce Resilience Act
S665/HR 4942 Conrad 30 and Physician Access Reauthorization Act
CLIA Waiver
PREVENT Pandemics Act
CURES 2.0
To prevent across-the-board direct spending cuts
Cytotechnologist labor rates
Remote digital telepathology
S 1000/HR 2377 SALSA
S 2140 - Patient Eligibility Restoration Act
HR 977 - legislation that would repeal provisions prohibiting self-referrals to new or expanded POHs.
HR 1202/S 704 - REDI Act
HR 2761 - SPARC act
HR 2764/S1229 - Green New Deal for Health
HR 3248 - Diagnostic Lab Testing Transparency Act
H.R. 3561, the Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act of 2023
Student loan repayment for FPs
HR 4527 - HEALTH DATA Act
Primary Care and Health Workforce Expansion Act
S 1994 Counting Veterans Cancer Act
HR 4875 Doctors in our Borders Act
HR 2474 - Strengthening Medicare for Patients and Providers Act
Continuing Appropriations Act, 2024 and Other Extensions Act
Further Continuing Appropriations and Other Extensions Act, 2024
HR 6683
Gene Therapy
Precision Medicine Answers for Kids Today Act
S.3018/H.R.3173 the Improving Seniors Timely Access to Care Act of 2021
Dr. Lorna Breen Health Care Provider Protection Act
PREVAIL
HR 6371 - budget neutrality bill
EDUCATE Act - Murphy DEI Bill
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Issues relating to surprise medical bills
Pandemic and All-Hazards Preparedness Act (PAHPA) Reauthorization
Verifying Accurate Leading-Edge IVCT Development (VALID) Act
Advocating for relief from cuts to evaluation and management codes within Medicare
Issues relating to the debt limit
Issues relating to site-neutral payments
Issue relating to artificial intelligence
Issues relating to combatting fentanyl crisis
Issues relating to Medicare coverage pathways
Researching Long Covid
Fees paid on electronically submitting to insurers
Issues relating to the Clinical Laboratory Fee Schedule
Issues relating to forensic pathologist Loan repayment
funding for the CDC AMD program
Funding for lab test harmonization
Issues surrounding Health Data Privacy
Issues surrounding the Change Healthcare Cyber Attack
Agencies Lobbied
U.S. Senate U.S. House of Representatives
4th Quarter, 2023
In Q4, College of American Pathologists had in-house lobbyists. The report was filed on Jan. 23.
Original Filing: 301541568.xml
Lobbying Issues
HR2389/S1302 - Resident Physician Shortage Reduction Act
S2333 - Public Health Workforce Loan Repayment Act
Health Workforce Resilience Act
S665/HR 4942 Conrad 30 and Physician Access Reauthorization Act
CLIA Waiver
PREVENT Pandemics Act
CURES 2.0
To prevent across-the-board direct spending cuts
Cytotechnologist labor rates
Remote digital telepathology
S 1000/HR 2377 SALSA
S 2140 - Patient Eligibility Restoration Act
HR 977 - legislation that would repeal provisions prohibiting self-referrals to new or expanded POHs.
HR 1202/S 704 - REDI Act
HR 2761 - SPARC act
HR 2764/S1229 - Green New Deal for Health
HR 3248 - Diagnostic Lab Testing Transparency Act
H.R. 3561, the Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act of 2023
Student loan repayment for FPs
HR 4527 - HEALTH DATA Act
Primary Care and Health Workforce Expansion Act
S 1994 Counting Veterans Cancer Act
HR 4875 Doctors in our Borders Act
HR 2474 - Strengthening Medicare for Patients and Providers Act
S.2140 - Patent Eligibility Restoration Act of 2023
Continuing Appropriations Act, 2024 and Other Extensions Act
Further Continuing Appropriations and Other Extensions Act, 2024
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Issues relating to surprise medical bills
Pandemic and All-Hazards Preparedness Act (PAHPA) Reauthorization
Verifying Accurate Leading-Edge IVCT Development (VALID) Act
Advocating for relief from cuts to evaluation and management codes within Medicare
Issues relating to the debt limit
Issues relating to site-neutral payments
Issue relating to artificial intelligence
Issues relating to combatting fentanyl crisis
Issues relating to Medicare coverage pathways
Researching Long Covid
Fees paid on electronically submitting to insurers
Issues relating to the Clinical Laboratory Fee Schedule
Agencies Lobbied
U.S. Senate U.S. House of Representatives
3rd Quarter, 2023
In Q3, College of American Pathologists had in-house lobbyists. The report was filed on Oct. 30, 2023.
Original Filing: 301517975.xml
Lobbying Issues
HR2389/S1302 - Resident Physician Shortage Reduction Act
S2333 - Public Health Workforce Loan Repayment Act
Health Workforce Resilience Act
S665/HR 4942 Conrad 30 and Physician Access Reauthorization Act
CLIA Waiver
PREVENT Pandemics Act
CURES 2.0
To prevent across-the-board direct spending cuts
Cytotechnologist labor rates
Remote digital telepathology
S 1000/HR 2377 SALSA
S 2140 - Patient Eligibility Restoration Act
HR 977 - legislation that would repeal provisions prohibiting self-referrals to new or expanded POHs.
HR 1202/S 704 - REDI Act
HR 2761 - SPARC act
HR 2764/S1229 - Green New Deal for Health
HR 3248 - Diagnostic Lab Testing Transparency Act
H.R. 3561, the Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act of 2023
Student loan repayment for FPs
HR 4527 - HEALTH DATA Act
Primary Care and Health Workforce Expansion Act
S 1994 Counting Veterans Cancer Act
HR 4875 Doctors in our Borders Act
HR 2474 - Strengthening Medicare for Patients and Providers Act
S.2140 - Patent Eligibility Restoration Act of 2023
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Issues relating to surprise medical bills
Pandemic and All-Hazards Preparedness Act (PAHPA) Reauthorization
Verifying Accurate Leading-Edge IVCT Development (VALID) Act
Advocating for relief from cuts to evaluation and management codes within Medicare
Issues relating to the debt limit
Issues relating to site-neutral payments
Issue relating to artificial intelligence
Issues relating to combatting fentanyl crisis
Issues relating to Medicare coverage pathways
Researching Long Covid
Fees paid on electronically submitting to insurers
Issues relating to the Clinical Laboratory Fee Schedule
Agencies Lobbied
U.S. Senate U.S. House of Representatives
2nd Quarter, 2023
In Q2, College of American Pathologists had in-house lobbyists. The report was filed on July 21, 2023.
Original Filing: 301492935.xml
Lobbying Issues
HR2389/S1302 - Resident Physician Shortage Reduction Act
S2333 - Public Health Workforce Loan Repayment Act
Health Workforce Resilience Act
S665 - Conrad 30 and Physician Access Reauthorization Act
CLIA Waiver
PREVENT Pandemics Act
CURES 2.0
To prevent across-the-board direct spending cuts
Cytotechnologist labor rates
Remote digital telepathology
SALSA
S 2140 - Patient Eligibility Restoration Act
HR 977 - legislation that would repeal provisions prohibiting self-referrals to new or expanded POHs.
HR 1202/S 704 - REDI Act
HR 2761 - SPARC act
HR 2764/S1229 - Green New Deal for Health
HR 2474 - Medicare inflationary update
HR 3248 - Diagnostic Lab Testing Transparency Act
H.R. 3561, the Promoting Access to Treatments and Increasing Extremely Needed Transparency (PATIENT) Act of 2023
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Issues relating to surprise medical bills
Pandemic and All-Hazards Preparedness Act (PAHPA)
Verifying Accurate Leading-Edge IVCT Development (VALID) Act
Advocating for relief from cuts to evaluation and management codes within Medicare
Issues relating to the debt limit
Issues relating to site-neutral payments
Issue relating to artificial intelligence
Agencies Lobbied
U.S. Senate U.S. House of Representatives
1st Quarter, 2023
In Q1, College of American Pathologists had in-house lobbyists. The report was filed on April 26, 2023.
Original Filing: 301469264.xml
Lobbying Issues
Resident Physician Shortage Reduction Act
Public Health Workforce Loan Repayment Act
Health Workforce Resilience Act
Conrad 30 and Physician Access Reauthorization Act
CLIA Waiver
PREVENT Pandemics Act
CURES 2.0
To prevent across-the-board direct spending cuts
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Issues relating to surprise medical bills
Pandemic and All-Hazards Preparedness Act (PAHPA)
Verifying Accurate Leading-Edge IVCT Development (VALID) Act
Advocating for relief from cuts to evaluation and management codes within Medicare
Agencies Lobbied
U.S. Senate U.S. House of Representatives
4th Quarter, 2022
In Q4, College of American Pathologists had in-house lobbyists. The report was filed on Jan. 26, 2023.
Original Filing: 301445049.xml
Lobbying Issues
HR.2256/S.834 - Resident Physician Shortage Reduction Act of 2021
HR2503 Social Determinants Accelerator Act
HR. 379 - Improving Social Determinants of Health Act of 2021
S 3506 The Strengthening the Public Health Workforce Act
HR 6578 Public Health Workforce Loan Repayment Act
HR 6000 Cures 2.0
HR 1868 - to prevent across-the-board direct spending cuts and other purposes
HR 1319 - American Rescue Plan Act
Paul Coverdell Forensic Science Grant Program
S1666 - VITAL Act of 2021 - Verified Innovation Testing in American Laboratories Act of 2021
The Health Workforce Resilience Act
Conrad State 30 and Physician Access Reauthorization Act - J1 and H1B visas
CLIA Waiver
HR8337 - Continuing Appropriations Act, 2021 and Other Extensions Act
HR7585 - Health Equity and Accountability Act of 2022
Patent Reform
FDA Safety and Landmark Advancements (FDASLA) Act
Right Drug Dose Now (Right) Act
PREVENT Pandemics Act
HR5602 - BIO Preparedness Workforce Act of 2021
Consolidated Appropriations Act of 2023
PREVENT Pandemics Act (S. 3799)
S.5194 - Protecting Medicare Patients and Physicians Act
S 5033 - Patrick Leahy and Orrin G. Hatch Justice For All Act of 2022
S 5029 - Help Find the Missing Act
S 5230 - Billys Law
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
S.510 - Protecting Medicare and American Farmers from Sequester Cuts Act of 2021
HR 8702 & S 5007 - the Holding Providers Harmless From Medicare Cuts During COVID-19 Act of 2020
HR 3502 - Protecting People from Surprise Medical Bills Act
HR 3630 - to amend title XXVII of the Public Health Service Act
S 1370 - Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019
HR4128 - Verifying Accurate Leading Edge IVCT Development (VALID) Act of 2021
Prostate Cancer Misdiagnosis Elimination Act
Resident Physician Shortage Reduction Act of 2019, S 348, HR 1763
HR8800 - Supporting Medicare Providers Act
HR3173/S3018 - Improving Seniors' Timely Access to Care Act
HR8188- Saving Access to Laboratory Services Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
3rd Quarter, 2022
In Q3, College of American Pathologists had in-house lobbyists. The report was filed on Oct. 20, 2022.
Original Filing: 301413027.xml
Lobbying Issues
HR.2256/S.834 - Resident Physician Shortage Reduction Act of 2021
HR2503 Social Determinants Accelerator Act
HR. 379 - Improving Social Determinants of Health Act of 2021
S 3506 The Strengthening the Public Health Workforce Act
HR 5376 Build Back Better Act
HR 6578 Public Health Workforce Loan Repayment Act
HR 6000 Cures 2.0
HR 1868 - to prevent across-the-board direct spending cuts and other purposes
HR 1319 - American Rescue Plan Act
Paul Coverdell Forensic Science Grant Program
S1666 - VITAL Act of 2021 - Verified Innovation Testing in American Laboratories Act of 2021
The Health Workforce Resilience Act
Conrad State 30 and Physician Access Reauthorization Act - J1 and H1B visas
CLIA Waiver
HR8337 - Continuing Appropriations Act, 2021 and Other Extensions Act
HR7585 - Health Equity and Accountability Act of 2022
Patent Reform
FDA Safety and Landmark Advancements (FDASLA) Act
Right Drug Dose Now (Right) Act
PREVENT Pandemics Act
HR5602 - BIO Preparedness Workforce Act of 2021
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
S.510 - Protecting Medicare and American Farmers from Sequester Cuts Act of 2021
HR 5376 Build Back Better Act
HR 8702 & S 5007 - the Holding Providers Harmless From Medicare Cuts During COVID-19 Act of 2020
HR 8505 - to amend Title XVIII of the SS Act to provide for a one-year waiver of budget neutrality adjustments under the Medicare Physician Fee Schedule, and for other purposes.
HR 3502 - Protecting People from Surprise Medical Bills Act
HR 3630 - to amend title XXVII of the Public Health Service Act
HR 1384 - Medicare for All Act of 2019
HR 861 - End Surprise Billing Act of 2019
S 1266 - Protecting Patients from Surprise Medicare Bills Act
S 1531 - Stopping the Outrageous Practice of Surprise Medical Act of 2019
S 1370 - Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019
HR 345 - SMASH Act
S 1213 - Consumer Health Insurance Protection Act of 2019
Protecting Access to Medicare Act Gene Patents
HR4128 - Verifying Accurate Leading Edge IVCT Development (VALID) Act of 2021
Prostate Cancer Misdiagnosis Elimination Act
Eliminate Kickbacks in Recovery Act (EDRA)
Resident Physician Shortage Reduction Act of 2019, S 348, HR 1763
HR7213 - The Equitable Community Access to Pharmacist Services Act Infrastructure Investments and Jobs Act
HR8800 - Supporting Medicare Providers Act
HR3173/S3018 - Improving Seniors' Timely Access to Care Act
HR8188- Saving Access to Laboratory Services Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
2nd Quarter, 2022
In Q2, College of American Pathologists had in-house lobbyists. The report was filed on July 20, 2022.
Original Filing: 301390205.xml
Lobbying Issues
HR.2256/S.834 - Resident Physician Shortage Reduction Act of 2021
HR2503 Social Determinants Accelerator Act
HR. 379 - Improving Social Determinants of Health Act of 2021
S 3506 The Strengthening the Public Health Workforce Act
HR 5376 Build Back Better Act
HR 6578 Public Health Workforce Loan Repayment Act
HR 6000 Cures 2.0
HR 1868 - to prevent across-the-board direct spending cuts and other purposes
HR 1319 - American Rescue Plan Act
Paul Coverdell Forensic Science Grant Program
S1666 - VITAL Act of 2021 - Verified Innovation Testing in American Laboratories Act of 2021
The Health Workforce Resilience Act
Conrad State 30 and Physician Access Reauthorization Act - J1 and H1B visas
CLIA Waiver
HR8337 - Continuing Appropriations Act, 2021 and Other Extensions Act
HR7585 - Health Equity and Accountability Act of 2022
Patent Reform
FDA Safety and Landmark Advancements (FDASLA) Act
Right Drug Dose Now (Right) Act
PREVENT Pandemics Act
HR5602 - BIO Preparedness Workforce Act of 2021
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
S.510 - Protecting Medicare and American Farmers from Sequester Cuts Act of 2021
HR 5376 Build Back Better Act
HR 8702 & S 5007 - the Holding Providers Harmless From Medicare Cuts During COVID-19 Act of 2020
HR 8505 - to amend Title XVIII of the SS Act to provide for a one-year waiver of budget neutrality adjustments under the Medicare Physician Fee Schedule, and for other purposes.
HR 3502 - Protecting People from Surprise Medical Bills Act
HR 3630 - to amend title XXVII of the Public Health Service Act
HR 1384 - Medicare for All Act of 2019
HR 861 - End Surprise Billing Act of 2019
S 1266 - Protecting Patients from Surprise Medicare Bills Act
S 1531 - Stopping the Outrageous Practice of Surprise Medical Act of 2019
S 1370 - Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019
HR 345 - SMASH Act
S 1213 - Consumer Health Insurance Protection Act of 2019
Protecting Access to Medicare Act Gene Patents
HR4128 - Verifying Accurate Leading Edge IVCT Development (VALID) Act of 2021
Prostate Cancer Misdiagnosis Elimination Act
Eliminate Kickbacks in Recovery Act (EDRA)
Resident Physician Shortage Reduction Act of 2019, S 348, HR 1763
HR7213 - The Equitable Community Access to Pharmacist Services Act Infrastructure Investments and Jobs Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
1st Quarter, 2022
In Q1, College of American Pathologists had in-house lobbyists. The report was filed on April 14, 2022.
Original Filing: 301356013.xml
Lobbying Issues
HR.2256/S.834 - Resident Physician Shortage Reduction Act of 2021
HR2503 Social Determinants Accelerator Act
HR. 379 - Improving Social Determinants of Health Act of 2021
S 3506 The Strengthening the Public Health Workforce Act
HR 5376 Build Back Better Act
HR 6578 Public Health Workforce Loan Repayment Act
HR 6000 Cures 2.0
HR 1868 - to prevent across-the-board direct spending cuts and other purposes
HR 1319 - American Rescue Plan Act
Paul Coverdell Forensic Science Grant Program
S1666 - VITAL Act of 2021 - Verified Innovation Testing in American Laboratories Act of 2021
The Health Workforce Resilience Act
Conrad State 30 and Physician Access Reauthorization Act - J1 and H1B visas
CLIA Waiver
HR8337 - Continuing Appropriations Act, 2021 and Other Extensions Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
S.510 - Protecting Medicare and American Farmers from Sequester Cuts Act of 2021
HR 5376 Build Back Better Act
HR 8702 & S 5007 - the Holding Providers Harmless From Medicare Cuts During COVID-19 Act of 2020
HR 8505 - to amend Title XVIII of the SS Act to provide for a one-year waiver of budget neutrality adjustments under the Medicare Physician Fee Schedule, and for other purposes.
HR 3502 - Protecting People from Surprise Medical Bills Act
HR 3630 - to amend title XXVII of the Public Health Service Act
HR 1384 - Medicare for All Act of 2019
HR 861 - End Surprise Billing Act of 2019
S 1266 - Protecting Patients from Surprise Medicare Bills Act
S 1531 - Stopping the Outrageous Practice of Surprise Medical Act of 2019
S 1370 - Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019
HR 345 - SMASH Act
S 1213 - Consumer Health Insurance Protection Act of 2019
Protecting Access to Medicare Act Gene Patents
HR4128 - Verifying Accurate Leading Edge IVCT Development (VALID) Act of 2021
Prostate Cancer Misdiagnosis Elimination Act
Eliminate Kickbacks in Recovery Act (EDRA)
Resident Physician Shortage Reduction Act of 2019, S 348, HR 1763
The Infrastructure Investments and Jobs Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
4th Quarter, 2021
In Q4, College of American Pathologists had in-house lobbyists. The report was filed on Jan. 20, 2022.
Original Filing: 301335279.xml
Lobbying Issues
HR 5376 Build Back Better Act
HR 6578 Public Health Workforce Loan Repayment Act
HR 6000 Cures 2.0
HR 1868 - to prevent across-the-board direct spending cuts and other purposes
HR 1319 - American Rescue Plan Act
Paul Coverdell Forensic Science Grant Program
S1666 - VITAL Act of 2021 - Verified Innovation Testing in American Laboratories Act of 2021
The Health Workforce Resilience Act
Conrad State 30 and Physician Access Reauthorization Act - J1 and H1B visas
CLIA Waiver
HR8337 - Continuing Appropriations Act, 2021 and Other Extensions Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
HR 5376 Build Back Better Act
HR 8702 & S 5007 - the Holding Providers Harmless From Medicare Cuts During COVID-19 Act of 2020
HR 8505 - to amend Title XVIII of the SS Act to provide for a one-year waiver of budget neutrality adjustments under the Medicare Physician Fee Schedule, and for other purposes.
HR 3502 - Protecting People from Surprise Medical Bills Act
HR 3630 - to amend title XXVII of the Public Health Service Act
HR 1384 - Medicare for All Act of 2019
HR 861 - End Surprise Billing Act of 2019
S 1266 - Protecting Patients from Surprise Medicare Bills Act
S 1531 - Stopping the Outrageous Practice of Surprise Medical Act of 2019
S 1370 - Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019
HR 345 - SMASH Act
S 1213 - Consumer Health Insurance Protection Act of 2019
Protecting Access to Medicare Act Gene Patents
HR4128 - Verifying Accurate Leading Edge IVCT Development (VALID) Act of 2021
Prostate Cancer Misdiagnosis Elimination Act
Eliminate Kickbacks in Recovery Act (EDRA)
Resident Physician Shortage Reduction Act of 2019, S 348, HR 1763
The Infrastructure Investments and Jobs Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
3rd Quarter, 2021
In Q3, College of American Pathologists had in-house lobbyists. The report was filed on Oct. 19, 2021.
Original Filing: 301303134.xml
Lobbying Issues
HR 6578 Public Health Workforce Loan Repayment Act
Cures 2.0
HR 1868 - to prevent across-the-board direct spending cuts and other purposes
HR 1319 - American Rescue Plan Act
Paul Coverdell Forensic Science Grant Program
S1666 - VITAL Act of 2021 - Verified Innovation Testing in American Laboratories Act of 2021
The Health Workforce Resilience Act
Conrad State 30 and Physician Access Reauthorization Act - J1 and H1B visas
CLIA Waiver
HR8337 - Continuing Appropriations Act, 2021 and Other Extensions Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
HR 8702 & S 5007 - the Holding Providers Harmless From Medicare Cuts During COVID-19 Act of 2020
HR 8505 - to amend Title XVIII of the SS Act to provide for a one-year waiver of budget neutrality adjustments under the Medicare Physician Fee Schedule, and for other purposes.
HR 3502 - Protecting People from Surprise Medical Bills Act
HR 3630 - to amend title XXVII of the Public Health Service Act
HR 1384 - Medicare for All Act of 2019
HR 861 - End Surprise Billing Act of 2019
S 1266 - Protecting Patients from Surprise Medicare Bills Act
S 1531 - Stopping the Outrageous Practice of Surprise Medical Act of 2019
S 1370 - Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019
HR 345 - SMASH Act
S 1213 - Consumer Health Insurance Protection Act of 2019
Protecting Access to Medicare Act Gene Patents
HR4128 - Verifying Accurate Leading Edge IVCT Development (VALID) Act of 2021
Prostate Cancer Misdiagnosis Elimination Act
Eliminate Kickbacks in Recovery Act (EDRA)
Resident Physician Shortage Reduction Act of 2019, S 348, HR 1763
The Infrastructure Investments and Jobs Act
Build Back Better Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
2nd Quarter, 2021
In Q2, College of American Pathologists had in-house lobbyists. The report was filed on July 23, 2021.
Original Filing: 301292790.xml
Lobbying Issues
HR 6578 Public Health Workforce Loan Repayment Act
Cures 20.0
HR 1868 - to prevent across-the-board direct spending cuts and other purposes
HR 1319 - American Rescue Plan Act
Paul Coverdell Forensic Science Grant Program
S1666 - VITAL Act of 2021 - Verified Innovation Testing in American Laboratories Act of 2021
The Health Workforce Resilience Act
Conrad State 30 and Physician Access Reauthorization Act - J1 and H1B visas
CLIA Waiver
HR8337 - Continuing Appropriations Act, 2021 and Other Extensions Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
HR 8702 & S 5007 - the Holding Providers Harmless From Medicare Cuts During COVID-19 Act of 2020
HR 8505 - to amend Title XVIII of the SS Act to provide for a one-year waiver of budget neutrality adjustments under the Medicare Physician Fee Schedule, and for other purposes.
HR 3502 - Protecting People from Surprise Medical Bills Act
HR 3630 - to amend title XXVII of the Public Health Service Act
HR 1384 - Medicare for All Act of 2019
HR 861 - End Surprise Billing Act of 2019
S 1266 - Protecting Patients from Surprise Medicare Bills Act
S 1531 - Stopping the Outrageous Practice of Surprise Medical Act of 2019
S 1370 - Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019
HR 345 - SMASH Act
S 1213 - Consumer Health Insurance Protection Act of 2019
Protecting Access to Medicare Act Gene Patents
VALID - Verifying Accurate Leading Edge IVCT Development
Prostate Cancer Misdiagnosis Elimination Act
Eliminate Kickbacks in Recovery Act (EDRA)
Resident Physician Shortage Reduction Act of 2019, S 348, HR 1763
Agencies Lobbied
U.S. Senate U.S. House of Representatives
1st Quarter, 2021
In Q1, College of American Pathologists had in-house lobbyists. The report was filed on April 22, 2021.
Original Filing: 301268957.xml
Lobbying Issues
HR 6578 Public Health Workforce Loan Repayment Act
Cures 20.0
HR 1868 - to prevent across-the-board direct spending cuts and other purposes
HR 1319 - American Rescue Plan Act
Paul Coverdell Forensic Science Grant Program
The Diagnostic Accuracy & Information Act Independent Advisory Payment Boaqrds
S3512 - VITAL Act of 2020 - Verified Innovation Testing in American Laboratories Act of 2020
The Health Workforce Resilience Act
Conrad State 30 and Physician Access Reauthorization Act
CLIA Waiver
HR8337 - Continuing Appropriations Act, 2021 and Other Extensions Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
HR 8702 & S 5007 - the Holding Providers Harmless From Medicare Cuts During COVID-19 Act of 2020
HR 8505 - to amend Title XVIII of the SS Act to provide for a one-year waiver of budget neutrality adjustments under the Medicare Physician Fee Schedule, and for other purposes.
HR 3502 - Protecting People from Surprise Medical Bills Act
HR 3630 - to amend title XXVII of the Public Health Service Act
HR 1384 - Medicare for All Act of 2019
HR 861 - End Surprise Billing Act of 2019
S 1266 - Protecting Patients from Surprise Medicare Bills Act
S 1531 - Stopping the Outrageous Practice of Surprise Medical Act of 2019
S 1370 - Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019
HR 345 - SMASH Act
S 1213 - Consumer Health Insurance Protection Act of 2019
Protecting Access to Medicare Act Gene Patents
VALID - Verifying Accurate Leading Edge IVCT Development
Prostate Cancer Misdiagnosis Elimination Act
Eliminate Kickbacks in Recovery Act (EDRA)
Resident Physician Shortage Reduction Act of 2019, S 348, HR 1763
Agencies Lobbied
U.S. Senate U.S. House of Representatives
4th Quarter, 2020
In Q4, College of American Pathologists had in-house lobbyists. The report was filed on Jan. 19, 2021.
Original Filing: 301234650.xml
Lobbying Issues
Paul Coverdell Forensic Science Grant Program
The Diagnostic Accuracy & Information Act Independent Advisory Payment Boards
S3512, VITAL Act of 2020 - Verified Innovative Testing in American Laboratories Act of 2020
Health and Economic Recovery Omnibus Emergency Solutions Act (HEROES Act)
Coronavirus Aid, Relief, and Economic Securities (CARES) Act
The Health Workforce Resilience Act
"Conrad State 30 and Physician Access Reauthorization Act
Clia Waiver
HR8337 - Continuing Appropriations Act, 2021 and Other Extensions Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
HR3502 Protecting People From Surprise Medical Bills Act
H.R. 3630: To amend title XXVII of the Public Health Service Act
HR. 1384: Medicare for All Act of 2019
H.R. 861: End Surprise Billing Act of 2019
S. 1266: Protecting Patients from Surprise Medical Bills Act
S. 1531: Stopping The Outrageous Practice of Surprise Medical Bills Act of 2019
S. 1379: Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019
H.R. 345: SMASH Act
S. 1213: Consumer Health Insurance Protection Act of 2019
Protecting Access to Medicare Act Gene Patients
VALID - Verifying Accurate Leading Edge IVCT Development
Prostate Cancer Misdiagnosis Elimination Act
Eliminate Kickbacks in Recovery Act (EDRA)
Resident Physician Shortage Reduction Act of 2019, S348, HR 1763
Agencies Lobbied
U.S. Senate U.S. House of Representatives
3rd Quarter, 2020
In Q3, College of American Pathologists had in-house lobbyists. The report was filed on Oct. 20, 2020.
Original Filing: 301218624.xml
Lobbying Issues
Paul Coverdell Forensic Science Grant Program
The Diagnostic Accuracy & Information Act Independent Advisory Payment Boards
S3512, VITAL Act of 2020 - Verified Innovative Testing in American Laboratories Act of 2020
Health and Economic Recovery Omnibus Emergency Solutions Act (HEROES Act)
Coronavirus Aid, Relief, and Economic Securities (CARES) Act
The Health Workforce Resilience Act
"Conrad State 30 and Physician Access Reauthorization Act
Clia Waiver
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
HR3502 Protecting People From Surprise Medical Bills Act
H.R. 3630: To amend title XXVII of the Public Health Service Act
HR. 1384: Medicare for All Act of 2019
H.R. 861: End Surprise Billing Act of 2019
S. 1266: Protecting Patients from Surprise Medical Bills Act
S. 1531: Stopping The Outrageous Practice of Surprise Medical Bills Act of 2019
S. 1379: Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019
H.R. 345: SMASH Act
S. 1213: Consumer Health Insurance Protection Act of 2019
Protecting Access to Medicare Act Gene Patients
VALID - Verifying Accurate Leading Edge IVCT Development
Prostate Cancer Misdiagnosis Elimination Act
Eliminate Kickbacks in Recovery Act (EDRA)
Resident Physician Shortage Reduction Act of 2019, S348, HR 1763
Agencies Lobbied
U.S. Senate U.S. House of Representatives
2nd Quarter, 2020
In Q2, College of American Pathologists had in-house lobbyists. The report was filed on July 20, 2020.
Original Filing: 301195365.xml
Lobbying Issues
Paul Coverdell Forensic Science Grant Program
The Diagnostic Accuracy & Information Act Independent Advisory Payment Boards
S3512, VITAL Act of 2020 - Verified Innovative Testing in American Laboratories Act of 2020
Health and Economic Recovery Omnibus Emergency Solutions Act (HEROES Act)
Coronavirus Aid, Relief, and Economic Securities (CARES) Act
The Health Workforce Resilience Act
"Conrad State 30 and Physician Access Reauthorization Act
Clia Waiver
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
HR3502 Protecting People From Surprise Medical Bills Act
H.R. 3630: To amend title XXVII of the Public Health Service Act
HR. 1384: Medicare for All Act of 2019
H.R. 861: End Surprise Billing Act of 2019
S. 1266: Protecting Patients from Surprise Medical Bills Act
S. 1531: Stopping The Outrageous Practice of Surprise Medical Bills Act of 2019
S. 1379: Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019
H.R. 345: SMASH Act
S. 1213: Consumer Health Insurance Protection Act of 2019
Protecting Access to Medicare Act Gene Patients
VALID - Verifying Accurate Leading Edge IVCT Development
Prostate Cancer Misdiagnosis Elimination Act
Eliminate Kickbacks in Recovery Act (EDRA)
Resident Physician Shortage Reduction Act of 2019, S348, HR 1763
Agencies Lobbied
U.S. Senate U.S. House of Representatives
1st Quarter, 2020
In Q1, College of American Pathologists had in-house lobbyists. The report was filed on April 23, 2020.
Original Filing: 301180960.xml
Lobbying Issues
Paul Coverdell Forensic Science Grant Program
The Diagnostic Accuracy & Information Act Independent Advisory Payment Board
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
HR3502 Protecting People From Surprise Medical Bills Act
H.R. 3630: To amend title XXVII of the Public Health Service Act
HR. 1384: Medicare for All Act of 2019
H.R. 861: End Surprise Billing Act of 2019
S. 1266: Protecting Patients from Surprise Medical Bills Act
S. 1531: Stopping The Outrageous Practice of Surprise Medical Bills Act of 2019
S. 1379: Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019
H.R. 345: SMASH Act
S. 1213: Consumer Health Insurance Protection Act of 2019
Protecting Access to Medicare Act Gene Patients
VALID - Verifying Accurate Leading Edge IVCT Development
Prostate Cancer Misdiagnosis Elimination Act
Eliminate Kickbacks in Recovery Act (EDRA)
Resident Physician Shortage Reduction Act of 2019, S348, HR 1763
Agencies Lobbied
U.S. Senate U.S. House of Representatives
4th Quarter, 2019
In Q4, College of American Pathologists had in-house lobbyists. The report was filed on Jan. 14, 2020.
Original Filing: 301105622.xml
Lobbying Issues
Paul Coverdell Forensic Science Grant Program
The Diagnostic Accuracy & Information Act Independent Advisory Payment Board
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
HR3502 Protecting People From Surprise Medical Bills Act
H.R. 3630: To amend title XXVII of the Public Health Service Act
HR. 1384: Medicare for All Act of 2019
H.R. 861: End Surprise Billing Act of 2019
S. 1266: Protecting Patients from Surprise Medical Bills Act
S. 1531: Stopping The Outrageous Practice of Surprise Medical Bills Act of 2019
S. 1379: Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019
H.R. 345: SMASH Act
S. 1213: Consumer Health Insurance Protection Act of 2019
Protecting Access to Medicare Act Gene Patients
VALID - Verifying Accurate Leading Edge IVCT Development
Prostate Cancer Misdiagnosis Elimination Act
Eliminate Kickbacks in Recovery Act (EDRA)
Resident Physician Shortage Reduction Act of 2019, S348, HR 1763
Agencies Lobbied
U.S. Senate U.S. House of Representatives
3rd Quarter, 2019
In Q3, College of American Pathologists had in-house lobbyists. The report was filed on Oct. 16, 2019.
Original Filing: 301066342.xml
Lobbying Issues
Paul Coverdell Forensic Science Grant Program
The Diagnostic Accuracy & Information Act Independent Advisory Payment Board
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
HR3502 Protecting People From Surprise Medical Bills Act
H.R. 3630: To amend title XXVII of the Public Health Service Act
HR. 1384: Medicare for All Act of 2019
H.R. 861: End Surprise Billing Act of 2019
S. 1266: Protecting Patients from Surprise Medical Bills Act
S. 1531: Stopping The Outrageous Practice of Surprise Medical Bills Act of 2019
S. 1379: Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019
H.R. 345: SMASH Act
S. 1213: Consumer Health Insurance Protection Act of 2019
Protecting Access to Medicare Act Gene Patients
VALID - Verifying Accurate Leading Edge IVCT Development
Agencies Lobbied
U.S. Senate U.S. House of Representatives
2nd Quarter, 2019
In Q2, College of American Pathologists had in-house lobbyists. The report was filed on July 16, 2019.
Original Filing: 301046569.xml
Lobbying Issues
Paul Coverdell Forensic Science Grant Program
The Diagnostic Accuracy & Information Act Independent Advisory Payment Board
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
HR3502 Protecting People From Surprise Medical Bills Act
H.R. 3630: To amend title XXVII of the Public Health Service Act
HR. 1384: Medicare for All Act of 2019
H.R. 861: End Surprise Billing Act of 2019
S. 1266: Protecting Patients from Surprise Medical Bills Act
S. 1531: Stopping The Outrageous Practice of Surprise Medical Bills Act of 2019
S. 1379: Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019
H.R. 345: SMASH Act
S. 1213: Consumer Health Insurance Protection Act of 2019
Agencies Lobbied
U.S. Senate U.S. House of Representatives
1st Quarter, 2019
In Q1, College of American Pathologists had in-house lobbyists. The report was filed on April 22, 2019.
Original Filing: 301035794.xml
Lobbying Issues
American Health Care Act of 2017 (HR 1628)
Access to Precision Medicine Advancement Act
Resident Physician Shortage Reduction Act of 2017 (HR2267)
Better Care Reconciliation Act
Paul Coverdell Forensic Science Grant Program
The Diagnostic Accuracy & Information Act Independent Advisory Payment Board
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Valid Act discussion draft (LDTs)
HR 5812 - Creating Opportunities that Necessitate ew and Enhance Connections that Improve Opioid Navigation Strategies Act of 2018
S 2680 - Opioid Crisis Response Act of 2018
HR 3635 - Local Coverage Determination (LCD) Clarification Act of 2017
Promoting Integrity in Medicare Act (HR 2066)
Protecting Seniors' Access to Medicare Act (HR849)
Protecting Access to Medicare Act
Protecting Patients from Surprise Medical Bills (Cassidy Language)
FDA Technical Assistance to DAIA
S 2582 - Consumer Health Insurance Protection Act
S 284- End Surprise Billing Act
CMS Physician Fee Schedule Registry Measures
Agencies Lobbied
U.S. Senate U.S. House of Representatives
4th Quarter, 2018
In Q4, College of American Pathologists had in-house lobbyists. The report was filed on Jan. 22, 2019.
Original Filing: 301013925.xml
Lobbying Issues
American Health Care Act of 2017 (H.R. 1628)
Access to Precision Medicine Advancement Act
Resident Physician Shortage Reduction Act of 2017 (H.R.2267)
Better Care Reconciliation Act
Paul Coverdell Forensic Science Grant Program
The Diagnostic Accuracy & Innovation Act Independent Advisory Payment Board
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
H.R.5812 - Creating Opportunities that Necessitate New and Enhanced Connections That Improve Opioid Navigation Strategies Act of 2018
H.R. 6 - Opioid Package
S.2680 - Opioid Crisis Response Act of 2018
H.R.3635 - Local Coverage Determination Clarification Act of 2017
Local Coverage Determination (LCD) Clarification Act (S. 794)
Promoting Integrity in Medicare Act (HR 2066)
Protecting Seniors' Access to Medicare Act (HR 849)
Protecting Access to Medicare Act
Protecting Patients from Surprise Medical Bills (Cassidy Language)
FDA Technical Assistance to DAIA
S. 2582 - Consumer Health Insurance Protection Act
S. 284 - End Surprise Billing Act
CMS Physician Fee Schedule Registry Measures
Agencies Lobbied
U.S. Senate U.S. House of Representatives
3rd Quarter, 2018
In Q3, College of American Pathologists had in-house lobbyists. The report was filed on Oct. 19, 2018.
Original Filing: 300990025.xml
Lobbying Issues
American Health Care Act of 2017 (H.R. 1628)
Access to Precision Medicine Advancement Act
Resident Physician Shortage Reduction Act of 2017 (H.R.2267)
Better Care Reconciliation Act
Paul Coverdell Forensic Science Grant Program
The Diagnostic Accuracy & Innovation Act Independent Advisory Payment Board
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
H.R.5812 - Creating Opportunities that Necessitate New and Enhanced Connections That Improve Opioid Navigation Strategies Act of 2018
H.R. 6 - Opioid Package
S.2680 - Opioid Crisis Response Act of 2018
H.R.3635 - Local Coverage Determination Clarification Act of 2017
Local Coverage Determination (LCD) Clarification Act (S. 794)
Promoting Integrity in Medicare Act (HR 2066)
Protecting Seniors' Access to Medicare Act (HR 849)
Protecting Access to Medicare Act
Protecting Patients from Surprise Medical Bills (Cassidy Language)
FDA Technical Assistance to DAIA
S. 2582 - Consumer Health Insurance Protection Act
S. 284 - End Surprise Billing Act
CMS Physician Fee Schedule Registry Measures
Agencies Lobbied
U.S. Senate U.S. House of Representatives
2nd Quarter, 2018
In Q2, College of American Pathologists had in-house lobbyists. The report was filed on July 18, 2018.
Original Filing: 300967317.xml
Lobbying Issues
American Health Care Act of 2017 (H.R. 1628)
Access to Precision Medicine Advancement Act
Resident Physician Shortage Reduction Act of 2017 (H.R.2267)
Better Care Reconciliation Act
Paul Coverdell Forensic Science Grant Program
The Diagnostic Accuracy & Innovation Act Independent Advisory Payment Board
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
H.R.5812 - Creating Opportunities that Necessitate New and Enhanced Connections That Improve Opioid Navigation Strategies Act of 2018
S.2680 - Opioid Crisis Response Act of 2018
H.R.3635 - Local Coverage Determination Clarification Act of 2017
Local Coverage Determination (LCD) Clarification Act (S. 794)
Promoting Integrity in Medicare Act (HR 2066)
Protecting Seniors' Access to Medicare Act (HR 849)
Protecting Access to Medicare Act (HR 3635)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
1st Quarter, 2018
In Q1, College of American Pathologists had in-house lobbyists. The report was filed on April 25, 2018.
Original Filing: 300959136.xml
Lobbying Issues
American Health Care Act of 2017 (H.R. 1628)
Access to Precision Medicine Advancement Act
Resident Physician Shortage Reduction Act of 2017 (H.R.2267)
Better Care Reconciliation Act
Paul Coverdell Forensic Science Grant Program
The Diagnostic Accuracy & Innovation Act Independent Advisory Payment Board
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Local Coverage Determination (LCD) Clarification Act (S. 794)
Promoting Integrity in Medicare Act (HR 2066)
Protecting Seniors' Access to Medicare Act (HR 849)
Protecting Access to Medicare Act (HR 3635)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
4th Quarter, 2017
In Q4, College of American Pathologists had in-house lobbyists. The report was filed on Jan. 22, 2018.
Original Filing: 300935778.xml
Lobbying Issues
American Health Care Act of 2017 (H.R. 1628)
Access to Precision Medicine Advancement Act
Resident Physician Shortage Reduction Act of 2017 (H.R.2267)
Better Care Reconciliation Act
Paul Coverdell Forensic Science Grant Program
The Diagnostic Accuracy & Innovation Act Independent Advisory Payment Board
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Local Coverage Determination (LCD) Clarification Act (S. 794)
Promoting Integrity in Medicare Act (HR 2066)
Protecting Seniors' Access to Medicare Act (HR 849)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
3rd Quarter, 2017
In Q3, College of American Pathologists had in-house lobbyists. The report was filed on Oct. 20, 2017.
Original Filing: 300911138.xml
Lobbying Issues
American Health Care Act of 2017 (H.R. 1628)
Access to Precision Medicine Advancement Act
Resident Physician Shortage Reduction Act of 2017 (H.R.2267)
Better Care Reconciliation Act
Paul Coverdell Forensic Science Grant Program
The Diagnostic Accuracy & Innovation Act Independent Advisory Payment Board
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Local Coverage Determination (LCD) Clarification Act (S. 794)
Promoting Integrity in Medicare Act (HR 2066)
Protecting Seniors' Access to Medicare Act (HR 849)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
2nd Quarter, 2017
In Q2, College of American Pathologists had in-house lobbyists. The report was filed on July 19, 2017.
Original Filing: 300888577.xml
Lobbying Issues
American Health Care Act of 2017 (H.R. 1628)
Access to Precision Medicine Advancement Act
Resident Physician Shortage Reduction Act of 2017 (H.R.2267)
Better Care Reconciliation Act
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Local Coverage Determination (LCD) Clarification Act (S. 794)
Promoting Integrity in Medicare Act (HR 2066)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
1st Quarter, 2017
In Q1, College of American Pathologists had in-house lobbyists. The report was filed on April 20, 2017.
Original Filing: 300873138.xml
Lobbying Issues
American Health Care Act of 2017 (H.R. 1628)
Preserving Employee Wellness Programs Act (HR 1313)
End Surprise Billing Act (S. 284)
Diagnostic Accuracy and Innovation Act (LDTs)
Labor and Health Appropriations (Harmonize reporting of clinical lab tests)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Local Coverage Determination (LCD) Clarification Act (S. 794)
Promoting Integrity in Medicare Act (HR 2066)
Agencies Lobbied
U.S. Senate U.S. House of Representatives
4th Quarter, 2016
In Q4, College of American Pathologists had in-house lobbyists. The report was filed on Jan. 23, 2017.
Original Filing: 300855780.xml
Lobbying Issues
HR34 and HR6 - 21st Century Cures Act
Senate - Innovation for Healthier Americans
Laboratory Developed Tests
Health Information Technology - Ensure pathologists are exempt from payment penalties under meaningful use standards.
HR2124 and S1148 GME - to increase the number of federally funed residency slotts
Stark self-referral law
Veterans Affairs provider reimbursement
S2392 and HR4227 - Network adequacy of hospital based physicians
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Paul Coverdell - Forensics
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Law Enforcement/Crime/Criminal Justice
Lobbying Issues
HR. 5721 and S. 3392 - Medicare Adminstrative Contractors/Local Coverage Determinations
Agencies Lobbied
U.S. Senate U.S. House of Representatives
3rd Quarter, 2016
In Q3, College of American Pathologists had in-house lobbyists. The report was filed on Oct. 13, 2016.
Original Filing: 300827242.xml
Lobbying Issues
HR6 - 21st Century Cures Act
Senate - Innovation for Healthier Americans
Laboratory Developed Tests
Health Information Technology - Ensure pathologists are exempt from payment penalties under meaningful use standards.
HR2124 and S1148 GME - to increase the number of federally funed residency slotts
Stark self-referral law
Veterans Affairs provider reimbursement
S2392 and HR4227 - Network adequacy of hospital based physicians
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Paul Coverdell - Forensics
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Law Enforcement/Crime/Criminal Justice
Lobbying Issues
HR. 5721 and S. 3392 - Medicare Adminstrative Contractors/Local Coverage Determinations
Agencies Lobbied
U.S. Senate U.S. House of Representatives
2nd Quarter, 2016
In Q2, College of American Pathologists had in-house lobbyists. The report was filed on July 18, 2016.
Original Filing: 300811142.xml
Lobbying Issues
HR6 - 21st Century Cures Act
Senate - Innovation for Healthier Americans
Laboratory Developed Tests
Health Information Technology - Ensure pathologists are exempt from payment penalties under meaningful use standards.
HR2124 and S1148 GME - to increase the number of federally funed residency slotts
Stark self-referral law
Veterans Affairs provider reimbursement
S2392 and HR4227 - Network adequacy of hospital based physicians
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Paul Coverdell - Forensics
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Law Enforcement/Crime/Criminal Justice
Lobbying Issues
Medicare Adminstrative Contractors/Local Coverage Determinations
Agencies Lobbied
U.S. Senate U.S. House of Representatives
1st Quarter, 2016
In Q1, College of American Pathologists had in-house lobbyists. The report was filed on April 14, 2016.
Original Filing: 300791002.xml
Lobbying Issues
HR6 - 21st Century Cures Act
Senate - Innovation for Healthier Americans
Laboratory Developed Tests
Health Information Technology - Ensure pathologists are exempt from payment penalties under meaningful use standards.
HR2124 and S1148 GME - to increase the number of federally funed residency slotts
Stark self-referral law
Veterans Affairs provider reimbursement
S2392 and HR4227 - Network adequacy of hospital based physicians
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Paul Coverdell - Forensics
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Law Enforcement/Crime/Criminal Justice
Lobbying Issues
Medicare Adminstrative Contractors/Local Coverage Determinations
Agencies Lobbied
U.S. Senate U.S. House of Representatives
4th Quarter, 2015
In Q4, College of American Pathologists had in-house lobbyists. The report was filed on Jan. 18, 2016.
Original Filing: 300774110.xml
Lobbying Issues
House - 21st Century Cures Act -
Senate - Innovation for Healthier Americans
Laboratory Developed Tests
Medicare Administration Contractors/Local Coverage Determination
Health Information Technology - Ensure pathologists are exempt from payment penalties under the meaningful use standards
GME - proposed legislation to increase the number of federally funded residency slots
Stark Self-Referral Law
Veterans Affairs provider reimbursement
Paul Coverdell Act - Forensics
Agencies Lobbied
U.S. Senate U.S. House of Representatives
3rd Quarter, 2015
In Q3, College of American Pathologists had in-house lobbyists. The report was filed on Oct. 19, 2015.
Original Filing: 300756516.xml
Lobbying Issues
House - 21st Century Cures Act - Laboratory Developed Tests (LDTs) and Medicare Administrative Contractors (MACs)/Local Coverage Determination (LCD)
Senate - Innovation for Healthier Americans; MACs and LDTs
Health Information Technology - Ensure pathologists are exempt from payment penalties under the meaningful use standards
GME - proposed legislation to increase the number of federally funded residency slots
Stark Self-Referral Law
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
Physician Quality Report System (PQRS)- define outcomes
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Law Enforcement/Crime/Criminal Justice
2nd Quarter, 2015
In Q2, College of American Pathologists had in-house lobbyists. The report was filed on July 20, 2015.
Original Filing: 300741338.xml
Lobbying Issues
House - 21st Century Cures Act - Laboratory Developed Tests (LDTs) and Medicare Administrative Contractors (MACs)/Local Coverage Determination (LCD)
Senate - Innovation for Healthier Americans; MACs and LDTs
Health Information Technology - Ensure pathologists are exempt from payment penalties under the meaningful use standards
GME - proposed legislation to increase the number of federally funded residency slots
Stark Self-Referral Law
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
H.R. 2, The Medicare Access and CHIP Reauthorization Act, to repeal the sustainable growth rate(SGR)formula that adjusts Medicare payments to physicians.
Physician Quality Report System (PQRS)- define outcomes
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Law Enforcement/Crime/Criminal Justice
1st Quarter, 2015
In Q1, College of American Pathologists had in-house lobbyists. The report was filed on April 17, 2015.
Original Filing: 300718591.xml
Lobbying Issues
House - 21st Century Cures Act - Laboratory Developed Tests (LDTs) and Medicare Administrative Contractors (MACs)/Local Coverage Determination (LCD)
Senate - Innovation for Healthier Americans; MACs and LDTs
Health Information Technology - Ensure pathologists are exempt from payment penalties under the meaningful use standards
GME - proposed legislation to increase the number of federally funded residency slots
Stark Self-Referral Law
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
H.R. 2, The Medicare Access and CHIP Reauthorization Act, to repeal the sustainable growth rate(SGR)formula that adjusts Medicare payments to physicians.
H.R.1470 - SGR Repeal and Medicare Provider Payment Modernization Act of 2015, repeals SGR formula and establishes new physican payment update systems.
Physician Quality Report System (PQRS)- define outcomes
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Law Enforcement/Crime/Criminal Justice
4th Quarter, 2014
College of American Pathologists amended a lobbying report for in-house lobbying in Q42014 on April 13, 2015
Original Filing: 300714345.xml
Lobbying Issues
HR 1309 - Health Information Technology Action of 2013 - Excludes pathologists from receiving incentives for purchasing electronic
health records as well as being exempt from payment penalties under meaningful use standards.
HR 1180, S 577, HR 2914 - GME legislation - proposed legislation to increase the number of federally funded residency slots
HR 2914 - Stark Self-Referral Law
HR 4250, S 2141 - Sunscreen Innovation Act.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
HR 4015, S 2000 - SGR Repeal and Medicare Provider Payment Modernization Act - Repeals SGR formula and establishes new
physician payment update system.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Law Enforcement/Crime/Criminal Justice
4th Quarter, 2014
In Q4, College of American Pathologists had in-house lobbyists. The report was filed on Jan. 12, 2015.
Original Filing: 300693915.xml
Lobbying Issues
HR 1309 - Health Information Technology Action of 2013 - Excludes pathologists from receiving incentives for purchasing electronic
health records as well as being exempt from payment penalties under meaningful use standards.
HR 1180, S 577, HR 2914 - GME legislation - proposed legislation to increase the number of federally funded residency slots
HR 2914 - Stark Self-Referral Law
HR 4250, S 2141 - Sunscreen Innovation Act.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
HR 4015, S 2000 - SGR Repeal and Medicare Provider Payment Modernization Act - Repeals SGR formula and establishes new
physician payment update system.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Law Enforcement/Crime/Criminal Justice
3rd Quarter, 2014
College of American Pathologists amended a lobbying report for in-house lobbying in Q32014 on Oct. 22, 2014
Original Filing: 300689811.xml
Lobbying Issues
HR 1309 - Health Information Technology Action of 2013 - Excludes pathologists from receiving incentives for purchasing electronic health records as well as being exempt from payment penalties under meaningful use standards.
HR 1180, S 577, HR 2914 - GME legislation - proposed legislation to increase the number of federally funded residency slots
HR 2914 - Stark Self-Referral Law
HR 4250, S 2141 - Sunscreen Innovation Act.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
HR 4015, S 2000 - SGR Repeal and Medicare Provider Payment Modernization Act - Repeals SGR formula and establishes new physician payment update system.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Law Enforcement/Crime/Criminal Justice
3rd Quarter, 2014
In Q3, College of American Pathologists had in-house lobbyists. The report was filed on Oct. 20, 2014.
Original Filing: 300682978.xml
Lobbying Issues
HR 1309 - Health Information Technology Action of 2013 - Excludes pathologists from receiving incentives for purchasing electronic health records as well as being exempt from payment penalties under meaningful use standards.
HR 1180, S 577, HR 2914 - GME legislation - proposed legislation to increase the number of federally funded residency slots
HR 2914 - Stark Self-Referral Law
HR 4250, S 2141 - Sunscreen Innovation Act.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Lobbying Issues
HR 4015, S 2000 - SGR Repeal and Medicare Provider Payment Modernization Act - Repeals SGR formula and establishes new physician payment update system.
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Agencies Lobbied
U.S. Senate U.S. House of Representatives
Type of Issue
Law Enforcement/Crime/Criminal Justice
2nd Quarter, 2014
In Q2, College of American Pathologists had in-house lobbyists. The report was filed on July 21, 2014.
Original Filing: 300665306.xml
Lobbying Issues
HR 4015 - SGR Repeal and Medicare Provider Payment Modernization Act - Repeals SGR formula and establishes new physician payment update system.
S. 2000 - SGR Repeal and Medicare Provider Payment Modernization Act - Repeals SGR formula and establishes new physician
payment update systemStark Self-Referral Law
Electronic Health Records
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Law Enforcement/Crime/Criminal Justice
Lobbying Issues
HR 1309 - Health Information Technology Action of 2013 - Excludes pathologists from receiving incentives for purchasing electronic health records as well as being exempt from payment penalties under meaningful use standards.
HR 1180, S. 577, HR 2914 - GME legislation - proposed legislation to increase the number of federally funded residency slots
HR 2914 - Stark Self-Referral Law
Agencies Lobbied
U.S. House of Representatives U.S. Senate
1st Quarter, 2014
In Q1, College of American Pathologists had in-house lobbyists. The report was filed on April 15, 2014.
Original Filing: 300636104.xml
Lobbying Issues
HR2810 - Medicare Patient Access and Quality Improvement Act of 2013 - SGR
Stark Self-Referral Law
Electronic Health Record OIG Safe Harbor
2014 Physician Fee ScheduleS. 1871 - SGR Repeal and Medicare Beneficary Access Act of 2013
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Law Enforcement/Crime/Criminal Justice
Lobbying Issues
HR 1309 - Health Information Technology Act of 2013 - Excludeds pathologists from receiving incentives for purchasing electronic health records as well as being exempt from payment penalties under meaningful use standards.
HR 1180, S 577, HR 1201 - GME Legislation - proposed legislation to increase the number of federally funded residency slots
Stark Self-Referral Law - HR2914
Agencies Lobbied
U.S. House of Representatives U.S. Senate
4th Quarter, 2013
College of American Pathologists amended a lobbying report for in-house lobbying in Q42013 on March 28, 2014
Original Filing: 300632072.xml
Lobbying Issues
HR2810 - Medicare Patient Access and Quality Improvement Act of 2013 - SGR
Stark Self-Referral Law
Electronic Health Record OIG Safe Harbor
2014 Physician Fee ScheduleS. 1871 - SGR Repeal and Medicare Beneficary Access Act of 2013
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Law Enforcement/Crime/Criminal Justice
Lobbying Issues
HR 1309 - Health Information Technology Act of 2013 - Excludeds pathologists from receiving incentives for purchasing electronic health records as well as being exempt from payment penalties under meaningful use standards.
HR 1180, S 577, HR 1201 - GME Legislation - proposed legislation to increase the number of federally funded residency slots
Stark Self-Referral Law
Agencies Lobbied
U.S. House of Representatives U.S. Senate
4th Quarter, 2013
In Q4, College of American Pathologists had in-house lobbyists. The report was filed on Jan. 20, 2014.
Original Filing: 300620746.xml
Lobbying Issues
HR2810 - Medicare Patient Access and Quality Improvement Act of 2013 - SGR
Stark Self-Referral Law
Electronic Health Record OIG Safe Harbor
2014 Physician Fee ScheduleS. 1871 - SGR Repeal and Medicare Beneficary Access Act of 2013
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Law Enforcement/Crime/Criminal Justice
Lobbying Issues
HR 1309 - Health Information Technology Act of 2013 - Excludeds pathologists from receiving incentives for purchasing electronic health records as well as being exempt from payment penalties under meaningful use standards.
HR 1180, S 577, HR 1201 - GME Legislation - proposed legislation to increase the number of federally funded residency slots
Stark Self-Referral Law
Agencies Lobbied
U.S. House of Representatives U.S. Senate
3rd Quarter, 2013
College of American Pathologists amended a lobbying report for in-house lobbying in Q32013 on March 28, 2014
Original Filing: 300632070.xml
Lobbying Issues
HR 1309 - Health Information Technology Act of 2013 - Excludes pathologists from receiving incentives for purchasing electronic health records as well as being exempt from payment penalties under meaningful use standards
Stark Self-Referral Law
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Sustained Growth Rate (SGR) Medicare Physician Payment Reform
Stark Self-Referral Law
Electronic Health Record OIG Safe Harbor
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Law Enforcement/Crime/Criminal Justice
3rd Quarter, 2013
In Q3, College of American Pathologists had in-house lobbyists. The report was filed on Oct. 16, 2013.
Original Filing: 300594937.xml
Lobbying Issues
HR 1309 - Health Information Technology Act of 2013 - Excludes pathologists from receiving incentives for purchasing electronic health records as well as being exempt from payment penalties under meaningful use standards
Stark Self-Referral Law
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Sustained Growth Rate (SGR) Medicare Physician Payment Reform
Stark Self-Referral Law
Electronic Health Record OIG Safe Harbor
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Law Enforcement/Crime/Criminal Justice
2nd Quarter, 2013
College of American Pathologists amended a lobbying report for in-house lobbying in Q22013 on March 28, 2014
Original Filing: 300632071.xml
Lobbying Issues
HR 1309 - Health Information Technology Act of 2012 - Excludes pathologists from receiving incentives for purchasing electronic health records as well as being exempt from payment penalties under meaningful use standards.
Stark Self-Referral Law
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Sustained Growth Rate (SGR) Medicare Physician Payment Reform
Stark Self-Referral Law
Electronic Health Record OIG Safe Harbor
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Law Enforcement/Crime/Criminal Justice
2nd Quarter, 2013
In Q2, College of American Pathologists had in-house lobbyists. The report was filed on July 16, 2013.
Original Filing: 300573274.xml
Lobbying Issues
HR 1309 - Health Information Technology Act of 2012 - Excludes pathologists from receiving incentives for purchasing electronic health records as well as being exempt from payment penalties under meaningful use standards.
Stark Self-Referral Law
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Sustained Growth Rate (SGR) Medicare Physician Payment Reform
Stark Self-Referral Law
Electronic Health Record OIG Safe Harbor
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Law Enforcement/Crime/Criminal Justice
1st Quarter, 2013
In Q1, College of American Pathologists had in-house lobbyists. The report was filed on April 22, 2013.
Original Filing: 300563802.xml
Lobbying Issues
HR1309 - Health Information Technology Act of 2012 - Excludes pathologists from receivng incentives for purchasing electronic health records as well as being exempt from payment penalties under meaningful use standards.
Self-Referral Law
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Sustained Growth Rate (SGR) Medicare Physician Payment Reform
Stark Self-Referral Law
Electronic Health Record OIG Safe Harbor
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Law Enforcement/Crime/Criminal Justice
4th Quarter, 2012
In Q4, College of American Pathologists had in-house lobbyists. The report was filed on Jan. 22, 2013.
Original Filing: 300538542.xml
Lobbying Issues
HR 4066: Health Information Technology Reform Act of 2012 - Excludes pathologists from receiving incentives for purchasing electronic health records as well as being exempt from payment penalties under meaningful use standards.
Self-Referral Law
Proficiency Testing Referral - Reform of sanctions under the "Clinical Laboratory Improvement Amendments of 1988"HR 5651/S 3187: "Food and Drug Administration Reform Act" - Incentives to spur development of antibiotics and use of diagnostic testing.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Sustained Growth Rate (SGR) Medicare Physician Payment Reform
Stark Self-Referral Law
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
S 132: "Criminal Justice and Forensics Science Reform Act"
S 3378: "Forensic Science and Standards Act of 2012"
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Law Enforcement/Crime/Criminal Justice
3rd Quarter, 2012
In Q3, College of American Pathologists had in-house lobbyists. The report was filed on Oct. 22, 2012.
Original Filing: 300517985.xml
Lobbying Issues
HR 3207: Modernizing Laboratory Test Standards for Patients Act of 2011- Regulation of laboratory developed tests and genetic testing.
HR 4066: Health Information Technology Reform Act of 2012 - Excludes Pathologists from receiving incentives for purchasing electronic health records as well as being exempt from payment penalties under meaningful use standrds Self-Referral Law
Proficiency Testing Referral - Reform of sanctions under the "Clinical Laboratory Improvement Amendments of 1988"
HR 5651/S 3187: "Food and Drug Administration Reform Act" - Incentives to spur development of antibiotics and use of diagnositic testing.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
HR 3207: Modernizing Laboratory Test Standards for Patients Act of 2011- Regulation of laboratory developed tests and genetic testing
Sustained Growth Rate (SGR) Medicare Physician Payment Reform
Stark Self-Referral Law
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
S 132: "Criminal Justice and Forensic Science Reform Act"
S 3378: "Forensic Science and Standards Act of 2012"
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Law Enforcement/Crime/Criminal Justice
2nd Quarter, 2012
In Q2, College of American Pathologists had in-house lobbyists. The report was filed on July 20, 2012.
Original Filing: 300493931.xml
Lobbying Issues
- HR 3207 - Modernizing Laboratory Test Standards for Patients Act of 2011 - Regulation of laboratory developed tests and genetic testing.
- HR 4066 - "Health Information Technology Reform Act of 2012" - Excludes Pathologists from receiving incentives for purchasing electronic health records as well as being exempt from payment penalties under meaningful use standards- Self-Referral Law
- Proficiency Testing Referral - Reform of sanctions under the "Clinical Laboratory Improvement Amendments of 1988"
-HR 5651/S 3187 - "Food and Drug Administration Reform Act" - Incentives to spur development of antibiotics and use of diagnostic testing.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
-HR 3207 - "Modernizing Laboratory Test Standards for Patients Act of 2011" - Regulation of laboratory developed tests and genetic testing.
- Sustained Growth Rate (SGR) Medicare Physician Payment Reform
-Stark Self-Referral Law
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
- S 132 - "Criminal Justice and Forensic Science Reform Act"
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Law Enforcement/Crime/Criminal Justice
1st Quarter, 2012
In Q1, College of American Pathologists had in-house lobbyists. The report was filed on April 18, 2012.
Original Filing: 300463172.xml
Lobbying Issues
- HR 3207 - Modernizing Laboratory Test Standards for Patients Act of 2011 - Regulation of laboratory developed tests and genetic testing.
- Standards for implementation of health information technology (HIT) meaningful-use standards and impact on practice of pathology.- Self-Referral Law
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
-HR 3207 - Modernizing Laboratory Test Standards for Patients Act of 2011 - Regulation of laboratory developed tests and genetic testing.
-Sustained Growth Rate (SGR) Medicare Physician Payment Reform
-Stark Self-Referral Law-HR 3765, The Temporary Payroll Tax Cut Continuation Act of 2011
- HR 2461, S.1967 - Physician Pathology Services Continuation Act - Extension of existing law to allow independent laboratories under certain conditions to bill Medicare directly for the technical component of anatomic pathology services provided to hospital patients.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
S.132, Criminal Justice and Forensic Science Reform Act of 2011.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Law Enforcement/Crime/Criminal Justice
4th Quarter, 2011
In Q4, College of American Pathologists had in-house lobbyists. The report was filed on Jan. 19, 2012.
Original Filing: 300442876.xml
Lobbying Issues
- H.R. 3207 - Modernizing Laboratory Test Standards for Patients Act of 2011 - Regulation of laboratory developed tests and genetic testing.
- Standards for implementation of health information technology (HIT) meaningful-use standards and impact on practice of pathology - Stark Self-Referral Law
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
H.R. 3207 - Modernizing Laboratory Test Standards for Patients Act of 2011 - Regulation of laboratory developed tests and genetic testing.
- Sustained Growth Rate (SGR) Medicare Physician Payment Reform
- Stark Self-Referral LawH.R. 2461, S.1967 - Physician Pathology Services Continuity Act - Extension of existing law to allow independent laboratories, under certain conditions, to bill Medicare directly for the technical component of anatomic pathology services provided to hospital patients.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
S. 132 - Criminal Justice and Forensic Science Reform Act of 2011.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Law Enforcement/Crime/Criminal Justice
3rd Quarter, 2011
In Q3, College of American Pathologists had in-house lobbyists. The report was filed on Oct. 19, 2011.
Original Filing: 300421027.xml
Lobbying Issues
- H.R. 5, S. 218, Help Efficient, Accessible, Low-Cost Timely Healthcare (HEALTH) Act of 2011
- Promoting personalized medicine for better patient care, advanced diagnostic laboratory testing and regulaton of laboratory developed tests.
- Standards for implementation of meaningful-use standards and impact on practice of pathology
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
H.R. 2461, Physician Pathology Service Continuity Act - Extenstion of existing law to allow independent laboratories, under certain conditions, to bill Medicare directly for the technical component of anatomic pathology services provided to hospital patients.
- Stark Self-Referral Law
- Sustained Growth Rate (SGR) Medicare Physician Payment Reform
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
S. 132 - "Criminal Justice and Forensic Science Reform Act of 2011."
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Law Enforcement/Crime/Criminal Justice
2nd Quarter, 2011
In Q2, College of American Pathologists had in-house lobbyists. The report was filed on July 19, 2011.
Original Filing: 300397295.xml
Lobbying Issues
- H.R. 5, S. 218, Help Efficient, Accessible, Low-Cost Timely Healthcare (HEALTH) Act of 2011
- Promoting personalized medicine for better patient care, advanced diagnostic laboratory testing and regulaton of laboratory developed tests.
- Standards for implementation of meaningful-use standards and impact on practice of pathologyH.R. 1249, America Invents Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
- Extenstion of existing law to allow independent laboratories, under certain conditions, to bill Medicare directly for the technical component of anatomic pathology services provided to hospital patients.
- Stark Self-Referral Law
- Sustained Growth Rate (SGR) Medicare Physician Payment Reform
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
S. 132 - "Criminal Justice and Forensic Science Reform Act of 2011."
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Law Enforcement/Crime/Criminal Justice
1st Quarter, 2011
In Q1, College of American Pathologists had in-house lobbyists. The report was filed on April 20, 2011.
Original Filing: 300378746.xml
Lobbying Issues
- H.R. 5, S. 218, Help Efficient, Accessible, Low-Cost Timely Healthcare (HEALTH) Act of 2011
- Promoting personalized medicine for better patient care, advanced diagnostic laboratory testing and regulaton of laboratory developed tests.
- Standards for implementation of meaningful-use standards and impact on practice of pathology
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
- Extenstion of existing law to allow independent laboratories, under certain conditions, to bill Medicare directly for the technical component of anatomic pathology services provided to hospital patients.
- Stark Self-Referral Law
- Sustained Growth Rate (SGR) Medicare Physician Payment Reform
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
S. 132 - "Criminal Justice and Forensic Science Reform Act of 2011."
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Type of Issue
Law Enforcement/Crime/Criminal Justice
4th Quarter, 2010
In Q4, College of American Pathologists had in-house lobbyists. The report was filed on Jan. 20, 2011.
Original Filing: 300352583.xml
Lobbying Issues
- Armed Forces Institute of Pathology (AFIP) and Joint Pathology Center;
- Joint Pathology Center
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
- H.R. 5440, The Geonomic and Personalized Medicine Act;
- H.R. 5690, The Meaningful End to Defensive Medicine and Aimless Lawsuits (MedMal) Act of 2010;
- Hatch BETTER (Better Evaluation and Treatment Through Essential Regulatory Reform) Patient Care Act;
- HITECH Act Implementation/Meaningful Use;
- Draft Senate bill, "Criminal Justice and Forensic Science Reform Act of 2011."
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
- H.R. 2534, Physician Pathology Services Continuity Act of 2009; To amend title XVIII of the Social Security Act to provide for the treatment of certain physician pathology services under the Medicare Program;
- S. 947, Physician Pathology Services Continuity Act of 2009; To amend title XVIII of the Social Security Act to provide for
the treatment of certain physician pathology services under the Medicare Program;- H.R. 3081, Continuing Appropriations Act of 2011, advocated for short-term SGR fix;
- H.R. 4994, Medicare and Medicaid Extenders Act of 2010;
- H.R. 5712, Physician Payment and Therapy Relief Act of 2010;
- Section 3114 of H.R. 3590, The Patient Protection and Affordable Care Act;
- Stark Self-referral law
Agencies Lobbied
U.S. House of Representatives U.S. Senate
3rd Quarter, 2010
In Q3, College of American Pathologists had in-house lobbyists. The report was filed on Oct. 20, 2010.
Original Filing: 300327630.xml
Lobbying Issues
- Armed Forces Institute of Pathology (AFIP) and Joint Pathology Center
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
- Prepared questions for Members of Congress to be asked during September 2010 Committee on Science & Technology hearing
on Health Information Technology;
- H.R. 5440, The Geonomic and Personalized Medicine Act;
- H.R. 5690, The Meaningful End to Defensive Medicine and Aimless Lawsuits (MedMal) Act of 2010; - Hatch BETTER (Better Evaluation and Treatment Through Essential Regulatory Reform) Patient Care Act.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
- H.R. 2534, Physician Pathology Services Continuity Act of 2009; To amend title XVIII of the Social Security Act to provide for
the treatment of certain physician pathology services under the Medicare Program;
- S. 947, Physician Pathology Services Continuity Act of 2009; To amend title XVIII of the Social Security Act to provide for
the treatment of certain physician pathology services under the Medicare Program; - Section 3114 of (H.R. 3590) The Patient Protection and Affordable Care Act;
- Section 1877 (42 USC 1395) of the Social Security Act.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
2nd Quarter, 2010
In Q2, College of American Pathologists had in-house lobbyists. The report was filed on July 19, 2010.
Original Filing: 300294045.xml
Lobbying Issues
Armed Forces Institute of Pathology (AFIP) and Joint Pathology Center
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R. 5440, The Genomic and Personalized Medicine Act
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R. 4213, American Jobs and Closing Tax Loopholes Act of 2010 (SGR);
H.R. 3962, Preservation of Access to Care for Medicare Beneficiaries and Pension Relief Act of 2010 (SGR);
H.R. 2534, Physician Pathology Services Continuity Act of 2009: To amend title XVIII of the Social Security Act to provide for the treatment of certain physician pathology services under the Medicare Program;S. 947, Physician Pathology Services Continuity Act of 2009: To amend title XVIII of the Social Security Act to provide for the treatment of certain physician pathology services under the Medicare program.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
1st Quarter, 2010
In Q1, College of American Pathologists had in-house lobbyists. The report was filed on April 20, 2010.
Original Filing: 300274004.xml
Lobbying Issues
H.R. 4949, the World Class Military Medical Facilities Act. A bill designed to establish within the Office of the Secretary of Defense an office responsible for implementing all recommendations and requirements regarding military medical facilities in the National Capital Region, and for other purposes.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
H.R. 3590, the Patient Protection and Affordable Act: To expand health care insurance coverage for the uninsured, restrict current
current practices by health insurance companies, and to expand health care entitlement programs;
H.R. 3962, the Affordable Health Care for America Act: To provide affordable, quality health care for all Americans and reduce the growth in health care spending;
H.R. 4872, the Health Care and Education Reconciliation Act of 2010. The bill makes a number of health-related financing and revenue changes to the Patient Protection and Affordable Care Act enacted by H.R.3590 and modifies higher education assistance provisions;
*Worked on pending legislation concerning Genomics legislation to be introduced in the U.S. House of Representatives and U.S. Senate*
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
H.R. 3961, Medicare Physician Payment Reform Act of 2009: To amend title XVIII of the Social Security Act to reform the Medicare SGR payment system for physician and to reinstitute and update the Pay-As-You-Go requirement of budget neutrality on new tax and mandatory spending legislation, enforced by the threat of annual, automatic sequestration; (continued on next page)H.R. 4851, Continuing Extension Act of 2010;
H.R. 2534, Physician Pathology Services Continuity Act of 2009: To amend title XVIII of the Social Security Act to provide for the treatment of certain physician pathology services under the Medicare Program;
S. 947, Physician Pathology Services Continuity Act of 2009: To amend title XVIII of the Social Security Act to provide for the treatment of certain physician pathology services under the Medicare program.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
4th Quarter, 2009
In Q4, College of American Pathologists had in-house lobbyists. The report was filed on Jan. 20, 2010.
Original Filing: 300246897.xml
Lobbying Issues
H.R. 3200, the America's Affordable Health Choices Act of 2009: To provide affordable, quality health care for all Americans and reduce the growth in health care spending;
H.R. 3590, the Patient Protection and Affordable Act: To expand health care insurance coverage for the uninsured, restrict currentcurrent practices by health insurance companies, and to expand health care entitlement programs;
H.R. 3962, the Affordable Health Care for America Act: To provide affordable, quality health care for all Americans and reduce the growth in health care spending;
S. 1679, the Affordable Health Choices Act of 2009: To make quality, affordable health care available to all Americans, reduce costs and improve quality, disease prevention and strengthen the health care workforce;
S. 1796, the America's Healthy Future Act of 2009: To provide afforadable, quality health care for all Americans and reduce growth in health care spending.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
H.R. 3961, Medicare Physician Payment Reform Act of 2009: To amend title XVIII of the Social Security Act to reform the Medicare SGR payment system for physician and to reinstitute and update the Pay-As-You-Go requirement of budget neutrality on new tax and mandatory spending legislation, enforced by the threat of annual, automatic sequestration; (continued on next page)H.R. 1699, Patient Access to Critical Lab Tests Act: To require that certain complex diagnostic laboratory tests performed by an independent laboratory after a hospital outpatient encounter or inpatient stay during which the specimen involved was collected shall be treated as services for which payment may be made directly to the laboratory under part B of title XVIII of the Social Security Act;
H.R. 2534, Physician Pathology Services Continuity Act of 2009: To amend title XVIII of the Social Security Act to provide for the treatment of certain physician pathology services under the Medicare Program;
S. 1776, Medicare Physician Fairness Act of 2009: To amend title XVIII of the Social Security Act to provide for the update under the Medicare physician fee schedule for years beginning with 2010 and to sunset the application of the sustainable growth rate formula, and for other purposes;
S. 1220, Patient Access to Critical Lab Tests Act: To require that certain complex diagnostic laboratory tests performed by an independent laboratory after a hospital outpatient encounter or inpatient stay during which the specimen involved was collected shall be treated as services for which payment may be made directly to the laboratory under part B of title XVIII of the Social Security Act;
S. 947, Physician Pathology Services Continuity Act of 2009: To amend title XVIII of the Social Security Act to provide for the treatment of certain physician pathology services under the Medicare program.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
3rd Quarter, 2009
In Q3, College of American Pathologists had in-house lobbyists. The report was filed on Oct. 20, 2009.
Original Filing: 300220522.xml
Lobbying Issues
H.R.2534 & S.947: The Physician Pathology Services Continuity Act of 2009
To amend title XVIII of the Social Security Act to provide for the treatment of certain physician pathology services under the Medicare Program.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Chairman's Mark: America's Healthy Future Act of 2009
2nd Quarter, 2009
In Q2, College of American Pathologists had in-house lobbyists. The report was filed on July 20, 2009.
Original Filing: 300192226.xml
Lobbying Issues
S.717-21st Century Cancer Alert: A bill to modernize cancer research, increase access to preventative cancer services, provide cancer treatment and survivorship initiatives, and for other purposes, provisions relating to comprehensive coordinated cancer care; biorepositories.
Stillbirth Awareness Act-Increasing the rate of autopsies performed on stillborns for purposes of gathering information to decrease incident rates of stillbirth.
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
S. 295 - Medicare Quality and Payment Reform Act of 2009
To improve the quality and efficiency of the Medicare program through measurement of readmission rates
and resource use and to develop a pilot program to provide episodic payments to organized groups of
multispecialty and multilevel providers of services and suppliers for hospitalization episodes associated
with select, high cost diagnoses.
Senator Jeff Bingaman (D-NM) (continued on next page)H.R.1452 - Medicare Clinical Diagnostic Laboratory Fee Schedule Moderization Act of 2009
To require the Secretary of Health and Human Services to enter into negotiated rulemaking to modernize the Medicare part B fee schedule for clinical diagnostic laboratory tests and to amend title XVIII of the Social Security Act to adjust the fee for collecting specimens for clinical diagnostic laboratory tests under the Medicare Program.
Representative Bart Stupak (D-MI)
H.R. 2534 and S. 947 - the Physician Pathology Services Continuity Act of 2009
To amend title XVIII of the Social Security Act to provide for the treatment of certain physician pathology services under the Medicare Program.
Representative John S. Tanner (D-TN)
Agencies Lobbied
House of Representatives Senate
1st Quarter, 2009
College of American Pathologists amended a lobbying report for in-house lobbying in Q12009 on Oct. 20, 2009
Original Filing: 300220927.xml
Lobbying Issues
S.717: 21st Century Cancer Act
A bill to modernize cancer research, increase access to preventative cancer services, provide cancer treatment and survivorship initiatives, and for other purposes.
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
H.R. 1: American Recovery and Reinvestment Act S. 295: Medicare Quality and Payment Reform Act of 2009
A bill to amend title XVIII of the Social Security Act to improve the quality and efficiency of the Medicare program through measurement of readmission rates and resource use and to develop a pilot program to provide episodic payments to organized groups of multispecialty and multilevel providers of services and suppliers for hospitalization episodes associated with select, high cost diagnoses.
H.R.1452: Medicare Clinical Diagnostic Laboratory Fee Schedule Modernization Act of 2009
To require the Secretary of Health and Human Services to enter into negotiated rulemaking to modernize the Medicare part B fee schedule for clinical diagnostic laboratory tests and to amend title XVIII of the Social Security Act to adjust the fee for collecting specimens for clinical diagnostic laboratory tests under the Medicare Program.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
1st Quarter, 2009
In Q1, College of American Pathologists had in-house lobbyists. The report was filed on April 20, 2009.
Original Filing: 300162627.xml
Lobbying Issues
S.717 - 21st Century Cancer Alert
A bill to modernize cancer research, increase access to preventative cancer services, provide cancer treatment and survivorship initiatives, and for other purposes.
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
H.R. 1- American Recovery and Reinvestment Act- Stimulus Bill
(continued on next page)S. 295 - Medicare Quality and Payment Reform Act of 2009
To improve the quality and efficiency of the Medicare program through measurement of readmission rates and resource use and to develop a pilot program to provide episodic payments to organized groups of multispecialty and multilevel providers of services and suppliers for hospitalization episodes associated with select, high cost diagnoses.
Senator Bingaman (D-NM)
H.R.1452 - Medicare Clinical Diagnostic Laboratory Fee Schedule Moderization Act of 2009
To require the Secretary of Health and Human Services to enter into negotiated rulemaking to modernize the Medicare part B fee schedule for clinical diagnostic laboratory tests and to amend title XVIII of the Social Security Act to adjust the fee for collecting specimens for clinical diagnostic laboratory tests under the Medicare Program
Representative Bart Stupak (D-MI)
Agencies Lobbied
U.S. House of Representatives U.S. Senate
4th Quarter, 2008
In Q4, College of American Pathologists had in-house lobbyists. The report was filed on Jan. 21, 2009.
Original Filing: 300133063.xml
Lobbying Issues
H.R. 2626: The Comprehensive HealthCARE Act of 2007 - Ensure access to quality healthcare by providing tax credit for individuals who purchase health insurance.
H.R. 6179: The Promoting Health Information Technology Act of 2008 - Electronic Health Records - Ensure legislation would not adversely impact pathologists and advance the implementation of health IT to modernize health records and improve the delivery of health care.
H.R. 3800 / S. 1693: The Wired for Health Care Quality Act - Electronic Health Records - Ensure legislation would not adversely impact pathologists and advance the implementation of health IT to modernize health records and improve the delivery of health care.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
H.R. 1237 / S. 2510: The Cytology Proficiency Improvement Act of 2007 - Cytology Proficiency Testing - Support legislation that would modernize and improve an outdated federal proficiency test required by pathologists who examine Pap test to screen for cervical cancer.
S. 976: Genomics and Personalized Medicine Act of 2007 - Regulation of Genetic Testing - The CAP supports continued regulation of genetic testing through existing CLIA law.
S. 736: The Laboratory Test Improvement Act - Regulation of Genetic Testing - The CAP supports continued regulation of genetic testing through existing CLIA law.
H.R. 977: The Genomic Research and Accessibility Act - Gene Patents - Support legislation that prohibits gene patents or exempts lab based personnel from patent violations when performing laboratory developed tests.
Agencies Lobbied
U.S. House of Representatives U.S. Senate Defense - Dept of (DOD) Health & Human Services - Dept of (HHS) Office of Management & Budget (OMB)
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
H.R. 6761: Medicare Clinical Diagnostic Lab Fee Schedule Moderization Act of 2008 - Clinical Laboratory Fee Schedule - Ensure revised clinical laboratory payment process does not adversely affect pathology practice.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
H.R. 2642: The Supplemental Appropriations Act - Armed Forces Institute of Pathology - The CAP supports legislation that would preserve the key functions of the Armed Forces Institute of Pathology.
Agencies Lobbied
U.S. House of Representatives U.S. Senate
3rd Quarter, 2008
In Q3, College of American Pathologists had in-house lobbyists. The report was filed on Oct. 20, 2008.
Original Filing: 300108975.xml
Lobbying Issues
Electronic Health Records- Ensure legislation would not adversely impact pathologists and advance the implementation of health IT to modernize health records and improve the delivery of health care (H.R. 2626, the Comprehensive HealthCARE act of 2007, H.R. 6179, the Promoting Health Information Technology Act of 2008, S.1693 and H.R. 3800, the Wired for Health Care Quality Act)
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Cytology Proficiency Testing- Support legislation that would modernize and improve an outdated federal proficiency test required by pathologists who examine Pap test to screen for cervical cancer. (H.R. 1237 and S 2510 both named The Cytology Proficiency Improvement Act of 2007); Regulation of Genetic Testing- The CAP supports continued regulation of genetic testing through existing CLIA law (S. 976, Genomics and Personalized Medicine Act of 2007 and S. 736 the Laboratory Test Improvement Act); Genetic Discrimination- Support legislation banning employers from discrimination based on genetic information. (H.R. 483 and S. 358, both titled the Genetic Information Non Discrimination Act of 2007 and signed into law in spring 2008)
Gene Patents- Support legislation that prohibits gene patents or exempts lab based personnel from patent violations when performing laboratory developed tests. (H.R. 977, the Genomic Research and Accessibility Act)
Agencies Lobbied
U.S. House of Representatives U.S. Senate Defense - Dept of (DOD)
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Sustainable Growth Rate- Support legislation that would halt Medicare physician payment cuts and support a permanent replacement for the current sustainable growth rate (SGR) that reflects current medical costs. (H.R. 6331 Medicare Improvements for Patients and Providers Act of 2008, H.R. 2626, the Comprehensive HealthCARE act of 2007, S.2785, the Save Medicare Act of 2008); Technical Component Grandfather Support legislation that provides a permanent grandfather provision allowingindependent laboratories to bill Medicare directly for certain physician pathology services. (H.R. 6331 Medicare Improvements for Patients and Providers Act of 2008, H.R. 1105 and S. 458 the Physician Pathology Services Continuity Act of 2007)
Competitive Bidding Demonstration Project- Support legislation that would repeal the Medicare Laboratory Competitive Bidding Demonstration project for diagnostic laboratory services. (H.R. 6331 Medicare Improvements for Patients and Providers Act of 2008, H.R. 3453, the Community Clinical Laboratory Fairness in Competition Act of 2007, S 2099, the Preserving Access to Laboratory Services Act of 2007)
Relative Value Update Reform- Oppose efforts to replace the current relative value review process with a federal advisory committee.
Pay for Performance/Physician Quality Reporting Initiative (PQRI)- Ensure pathologists continue to have the option to participate in PQRI program and monitor for any potential harm. Support legislation that establishes and continues a bonus payment program under the PQRI. (H.R. 6331, Medicare Improvements for Patients and Providers Act of 2008)
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Armed Forces Institute of Pathology- The CAP supports legislation that would preserve the key functions of the Armed Forces Institute of Pathology (H.R. 2642, the Supplemental Appropriations Act)
Agencies Lobbied
U.S. House of Representatives U.S. Senate
2nd Quarter, 2008
In Q2, College of American Pathologists had in-house lobbyists. The report was filed on July 21, 2008.
Original Filing: 300081799.xml
Lobbying Issues
Electronic Health Records- Ensure legislation would not adversely impact pathologists and advance the implementation of health IT to modernize health records and improve the delivery of health care (H.R. 2626, the Comprehensive HealthCARE act of 2007, H.R. 6179, the Promoting Health Information Technology Act of 2008, S.1693 and H.R. 3800, the Wired for Health Care Quality Act)
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Cytology Proficiency Testing- Support legislation that would modernize and improve an outdated federal proficiency test required by pathologists who examine Pap test to screen for cervical cancer. (H.R. 1237 and S 2510 both named The Cytology Proficiency Improvement Act of 2007); Regulation of Genetic Testing- The CAP supports continued regulation of genetic testing through existing CLIA law (S. 976, Genomics and Personalized Medicine Act of 2007 and S. 736 the Laboratory Test Improvement Act); Genetic Discrimination- Support legislation banning employers from discrimination based on genetic information. (H.R. 483 and S. 358, both titled the Genetic Information Non Discrimination Act of 2007 and signed into law in spring 2008)
Gene Patents- Support legislation that prohibits gene patents or exempts lab based personnel from patent violations when performing laboratory developed tests. (H.R. 977, the Genomic Research and Accessibility Act)
Agencies Lobbied
U.S. House of Representatives U.S. Senate Defense - Dept of (DOD)
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
Sustainable Growth Rate- Support legislation that would halt Medicare physician payment cuts and support a permanent replacement for the current sustainable growth rate (SGR) that reflects current medical costs. (H.R. 6331 Medicare Improvements for Patients and Providers Act of 2008, H.R. 2626, the Comprehensive HealthCARE act of 2007, S.2785, the Save Medicare Act of 2008); Technical Component Grandfather Support legislation that provides a permanent grandfather provision allowingindependent laboratories to bill Medicare directly for certain physician pathology services. (H.R. 6331 Medicare Improvements for Patients and Providers Act of 2008, H.R. 1105 and S. 458 the Physician Pathology Services Continuity Act of 2007)
Competitive Bidding Demonstration Project- Support legislation that would repeal the Medicare Laboratory Competitive Bidding Demonstration project for diagnostic laboratory services. (H.R. 6331 Medicare Improvements for Patients and Providers Act of 2008, H.R. 3453, the Community Clinical Laboratory Fairness in Competition Act of 2007, S 2099, the Preserving Access to Laboratory Services Act of 2007)
Relative Value Update Reform- Oppose efforts to replace the current relative value review process with a federal advisory committee.
Pay for Performance/Physician Quality Reporting Initiative (PQRI)- Ensure pathologists continue to have the option to participate in PQRI program and monitor for any potential harm. Support legislation that establishes and continues a bonus payment program under the PQRI. (H.R. 6331, Medicare Improvements for Patients and Providers Act of 2008)
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
Armed Forces Institute of Pathology- The CAP supports legislation that would preserve the key functions of the Armed Forces Institute of Pathology (H.R. 2642, the Supplemental Appropriations Act)
Agencies Lobbied
U.S. House of Representatives U.S. Senate
1st Quarter, 2008
In Q1, College of American Pathologists had in-house lobbyists. The report was filed on April 18, 2008.
Original Filing: 300045438.xml
Lobbying Issues
H.R. 1237- Cytology Proficiency Improvement Act of 2007; H.R. 1105- Physician Pathology Services Continuity Act of 2007; S. 458- Physician Pathology Services Continuity Act of 2007; H. R. 3162- Children's Health and Medicare Protection Act; S. 624- National Breast and Cervical Cancer Early Detection Program Reauthorization Act of 2007; H.R. 1132 - National Breast and Cervical Cancer Early Detection Program Reauthorization Act of 2007 (Received in Senate from House); H.R. 2626- Comprehensive HealthCARE (Coverage and Reform Enhancement) Act; H.R. 2860- Health Care Access and Rural Equity (H-CARE) Act of 2007; S. 1605 -Craig Thomas Rural Hospital and Provider Equity Act of 2007; H.R. 506- Health Partnership Through Creative Federalism Act; S. 1693- Wired for Health Care Quality Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
H.R. 977- Genomic Research and Accessibility Act; S. 976- Genomics and Personalized Medicine Act of 2007;
S. 736- Laboratory Test Improvement Act- MED; S. 624- National Breast and Cervical Cancer Early Detection Program Reauthorization Act of 2007; H.R. 1132 - National Breast and Cervical Cancer Early Detection Program Reauthorization Act of 2007 (Received in Senate from House); H.R. 2626- Comprehensive HealthCARE (Coverage and Reform Enhancement) Act; H.R. 493- Genetic Information Nondiscrimination Act of 2007; S.358- Genetic Information Nondiscrimination Act of 2007
Agencies Lobbied
U.S. House of Representatives U.S. Senate Defense - Dept of (DOD)
Type of Issue
Medical/Disease Research/Clinical Labs
Lobbying Issues
H.R. 2580- Help, Efficient, Accessible, Low-Cost, Timely, Healthcare Act of 2007; S. 334- Healthy Americans Act
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
H.R. 1105- Physician Pathology Services Continuity Act of 2007; S. 458- Physician Pathology Services Continuity Act of 2007; H.R. 3453- The Community Clinical Laboratory Fairness in Competition Act of 2007; H.R. 2860- Health Care Access and Rural Equity (H-CARE) Act of 2007; S. 1605 -Craig Thomas Rural Hospital and Provider Equity Act of 2007
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Lobbying Issues
H.R. 1585- National Defense Authorization Act for FY 08; H.R 2206- US U.S. Troop Readiness, Veterans' Care, Katrina Recovery, and Iraq Accountability Appropriations Act, 2007; S. 1547- National Defense Authorization Act for FY 08
Agencies Lobbied
U.S. House of Representatives U.S. Senate
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate